Literature DB >> 428146

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.

N Thatcher, R Swindell, D Crowther.   

Abstract

The effects of a single immunization of melanoma patients with BCG or C. parvum on the blood counts, serum immunoglobulin levels and lymphoid subpopulations were followed by multiple assays over 28 days. C. parvum produced a decrease in the white cell count, lymphocyte count and lymphoid T and sIg+ cell numbers, which recovered within 1 week; BCG did not produce such a marked depression. Both agents were associated with increases in T cell numbers and lymphocyte PHA blastogenesis after the first week; these declined to pre-immunization values by 3-4 weeks. The sIg-bearing cell subpopulation also increased after BCG. Different methods of expression the results were compared and the difficulties of immunological monitoring are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428146      PMCID: PMC1537602     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Immunodepression after major surgery in normal patients.

Authors:  M S Slade; R L Simmons; E Yunis; L J Greenberg
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

2.  The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.

Authors:  J P Minton; J L Rossio; B Dixon; M C Dodd
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

4.  Correlation of in vivo and in vitro assays of immunocompetence in cancer patients.

Authors:  S H Golub; T X O'Connell; D L Morton
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

5.  Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.

Authors:  N J Gross; A C Eddie-Quartey
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

6.  Postoperative depression of lymphocyte transformation response to microbial antigens.

Authors:  H Kehlet; M Thomsen; M Kjaer; P Platz
Journal:  Br J Surg       Date:  1977-12       Impact factor: 6.939

7.  Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia.

Authors:  A C Campbell; P Hersey; I C MacLennan; H E Kay; M C Pike
Journal:  Br Med J       Date:  1973-05-19

8.  Immunological monitoring and immunotherapy in carcinoma of the lung.

Authors:  J L Weese; R B Herberman; E Perlin; M Mills; W Heims; J Blom; D Green; J Reid; S Bellinger; I Law; J L McCoy; J H Dean; G B Cannon; J Djeu
Journal:  Int J Cancer       Date:  1976-12-15       Impact factor: 7.396

9.  Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.

Authors:  S H Golub; A B Forsythe; D L Morton
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

10.  Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

Authors:  N Thatcher; M K Palmer; N Gasiunas; D Crowther
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

  10 in total
  4 in total

1.  Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

2.  Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

3.  Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus.

Authors:  B M von Blomberg; J Glerum; J J Croles; J Stam; H A Drexhage
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

4.  Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma.

Authors:  M H Mignot; J W Lens; H A Drexhage; B M von Blomberg; V D Flier; J Oort; J G Stolk
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.